Which statement by the client indicates an understanding of the administration of transdermal oxybutynin?
I will apply a new patch every day to ensure continuous medication levels.
I will apply the patch to my abdomen, hips, or buttocks and change it every 3 to 4 days.
I will take this medication orally with a full glass of water.
I will place the patch on my chest or upper arms for best absorption.
The Correct Answer is B
A. I will apply a new patch every day to ensure continuous medication levels: This is incorrect. The patch should be changed every 3 to 4 days, not daily.
B. I will apply the patch to my abdomen, hips, or buttocks and change it every 3 to 4 days: This is correct. Transdermal oxybutynin patches should be applied to the specified areas (abdomen, hips, or buttocks) and changed every 3 to 4 days.
C. I will take this medication orally with a full glass of water: This statement is incorrect as it refers to oral oxybutynin, not the transdermal form.
D. I will place the patch on my chest or upper arms for best absorption: This is incorrect as the patch should be placed on the abdomen, hips, or buttocks for optimal absorption.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is C
Explanation
A. Hypotension: Hypotension is not a common interaction between oxybutynin and haloperidol.
B. Lowered plasma concentrations: There is no significant interaction that would lead to lowered plasma concentrations of either medication.
C. Increased effect of the antispasmodic drug: Both oxybutynin and haloperidol have anticholinergic properties. When combined, these properties can increase the risk of anticholinergic side effects, such as dry mouth, constipation, and urinary retention, enhancing the effect of oxybutynin.
D. Decreased effect of the antipsychotic drug: There is no evidence that oxybutynin would decrease the effect of haloperidol.
Correct Answer is D
Explanation
A. Risk for impaired urinary elimination: Oxybutynin is used to treat urinary urgency, so it is unlikely to impair urinary elimination and may even improve it.
B. Risk for alteration in body image: There is no direct association between oxybutynin use and body image concerns.
C. Risk for alteration in bowel elimination: Oxybutynin can cause constipation, but this is not the highest priority compared to dry mouth.
D. Risk for altered comfort: dry mouth: Dry mouth is a common and bothersome side effect of oxybutynin, making comfort the highest priority concern.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.